PlainPharmaWatch

CMS Open Payments · Tool

Purdue Pharma L.P. vs Tosoh Bioscience, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Purdue Pharma L.P. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 9,551, versus 2,118 for the other company. Its single largest recorded recipient represents 97.7% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Purdue Pharma L.P.
HHI 9,551 · top recipient 97.7%
Ranked #151 of 1,838 companies by HHI
Tosoh Bioscience, Inc.
HHI 2,118 · top recipient 25.2%
Ranked #730 of 1,838 companies by HHI

Payment Overview

Company A

Purdue Pharma L.P.

Total Payments
$2.6M
% of Industry
0.0%
Transactions
326
Avg per Transaction
$7.9K
Recipients
309
Avg per Recipient
$8.4K
Payment Types
4
Top Payment Type
Consulting Fee
Total Payments
$2.6M
% of Industry
0.0%
Transactions
82
Avg per Transaction
$32.0K
Recipients
9
Avg per Recipient
$292.0K
Payment Types
1
Top Payment Type
Food and Beverage

Highlighted values indicate the higher figure for each metric.

Total payments compared

Purdue Pharma L.P. vs Tosoh Bioscience, Inc. - total reported payments in CMS Open Payments PY2024

Tosoh Bioscience, Inc.$2.6MPurdue Pharma L.P.$2.6M

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Purdue Pharma L.P.

Consulting Fee $1.9M

99.1%

Education $11.4K

0.6%

Food and Beverage $5.4K

0.3%

Gift $64.57

0.0%

Tosoh Bioscience, Inc.

Food and Beverage $290.85

100.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Purdue Pharma L.P.

  1. 1

    Duke University Hospital

    $1,846,025.14 · 21 txns

  2. 2

    Denver Health Medical Center

    $7,148.98 · 11 txns

  3. 3

    JEFFREY GALINKIN

    $6,712.00 · 4 txns

  4. 4

    RAYMOND ANTON

    $4,895.00 · 1 txns

  5. 5

    GLEN APSELOFF

    $4,615.00 · 1 txns

Tosoh Bioscience, Inc.

  1. 1

    JOHN JERNIGAN

    $73.35 · 2 txns

  2. 2

    NORMAN TAYLOR

    $73.35 · 2 txns

  3. 3

    JOEL MCCLOUD

    $73.35 · 2 txns

  4. 4

    DHARAMVEER SINGH

    $31.96 · 1 txns

  5. 5

    AUSTIN BARBER

    $19.42 · 1 txns

Summary Comparison

Metric Purdue Pharma L.P. Tosoh Bioscience, Inc.
Total Payments $2.6M $2.6M
% of Industry Total 0.0% 0.0%
Transaction Count 326 82
Avg per Transaction $7.9K $32.0K
Recipient Count 309 9
Avg per Recipient $8.4K $292.0K
Payment Type Count 4 1
Top Payment Type Consulting Fee Food and Beverage

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.